SB 149

  • Kentucky Senate Bill
  • 2024 Regular Session
  • Introduced in Senate Jan 30, 2024
  • Senate
  • House
  • Governor

AN ACT relating to prescription drugs.

Abstract

Amend KRS 304.17A-164 to establish cost-sharing requirements for prescription drugs; require rebates to be passed through; establish confidentiality requirements for the rebate information; create a new section of KRS 365.880 to 365.900 to provide that the actual amount of rebates received is a trade secret; provide that compliance with the prescription drugs cost-sharing and rebate requirements shall not be in violation of the Uniform Trade Secrets Act; amend KRS 304.17C-125, 304.38A-115, 18A.225, and 164.2871 to apply the cost-sharing and rebate requirements for prescription drugs to limited health service benefit plans, limited health service organizations, the state employee health plan, and self-insured employer group health plans provided by the governing board of a state postsecondary education institution; repeal KRS 304.38A-120, relating to assignment of certain benefits under limited health service organization plans, to consolidate like provisions; apply provisions to health plans issued or renewed on or after January 1, 2025; EFFECTIVE January 1, 2025.

Bill Sponsors (4)

Votes


No votes to display

Actions


Feb 01, 2024

Senate

to Banking & Insurance (S)

Jan 30, 2024

Senate

introduced in Senate

Senate

to Committee on Committees (S)

Bill Text

Bill Text Versions Format
Introduced PDF

Related Documents

Document Format
Fiscal Note PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Kentucky General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.